The Trustees of The University of Pennsylvania;Novartis AG;University of Pittsburgh - Of the Commonwealth System of Higher Education
发明人:
申请号：
EP19196212.5
公开号：
EP3626741A1
申请日:
2014.02.20
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The invention provides compositions and methods for treating diseases associated with expression of EGFRvIII. The invention also relates to chimeric antigen receptor (CAR) specific to EGFRvIII, vectors encoding the same, and recombinant T cells comprising the anti-EGFRvIII CAR. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises an anti-EGFRvIII binding domain.
